In summary, our study shows that aberrantly activated SALL4 may contribute to esophageal tumorigenesis by promoting malignant proliferation and inhibiting cell apoptosis, regulating ESCC cell migration, invasion and cell cycle. The gene discussed is SALL4; the disease is esophageal squamous cell carcinoma.